Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Interview: Maves Carries OTC Experience To Development Role At USP

This article was originally published in The Tan Sheet

Executive Summary

Michael Maves, president of the Consumer Healthcare Products Association from 1999 to 2001, talked to “The Tan Sheet” about his OTC sector history and his priorities for development at the U.S. Pharmacopeia.

You may also be interested in...

Supplement Science, Switch Advocacy Stressed At CHPA Conference

The Consumer Healthcare Products Association plans to pursue a science-driven approach in its dietary supplement agenda, CHPA President Michael Maves, MD, stated.

CHPA's New President Is ENT Surgeon, Academy Exec Michael Maves

The Consumer Healthcare Products Association went outside the industry but stayed within D.C. and the medical area to find its next president, Michael Maves, MD.

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts